2016 BioPacific Conference Agenda:

Theme: Shooting for the Stars – Entering the Dawn of Unprecedented Breakthroughs in Life Sciences & Medicine

May 7th, 2016, Saturday, San Francisco Bay Area at San Mateo Marriott, 1770 South Amphlett Blvd. San Mateo, CA 94402, U.S.A.

Morning Session I: Welcome & CABS K. Fong Award
Session Chair: Wentao Zhang, Ph.D.
8:45 AM – 8:50 AM Welcome Remarks
Cheni Kwok, Ph.D., CLP, President-Elect of CABS & 2016 BioPacific Conference Organizing Committee Chair
8:50 AM – 9:00 AM State of the Society
Jiangwen Majeti, Ph.D., MBA, President of CABS
9:00 AM – 9:10 AM CABS K. Fong Special Award: Visionary in Life Sciences
Presenter: Kenneth Fong, Ph.D., Chairman, Kenson Ventures
Awardee: Gerald Chan, Sc.D., Co-Founder, Morningside
9:10 AM – 10:00 AM Somewhere Between Science and Humanity
Gerald Chan, Sc.D., Co-Founder, Morningside
10:00 AM-10:20 AM BREAK
Morning Session II: Successful Business Models & Entrepreneurship
Session Chairs: Jessica Difei Sun, M.D. & Gavin Lu, Ph.D.
10:20 AM-10:55 AM M&A: An Insider’s Perspective
Hari Kumar, Ph.D., Ex-Chief Executive Officer & Board of Director, Adheron Therapeutics
10:55 AM – 11:30 AM Vaccines: Lessons from the Oldest Class of Biologics
Piers Whitehead, Executive Vice President & Chief Business Officer, PaxVax
11:30 – 12:00 PM Life Sciences Parks in China: Growth and Trends
Robert Lou, Manager Director, Ningbo Kangtaibo Technology Development Co. Ltd & Hui Zhang, Deputy Director, Ningbo Hangzhou Bay New Zone Investments and Partnership Branch
12:00 PM – 1:00 PM LUNCH BREAK
Afternoon Session I: Life Sciences Breakthroughs & Partnerships
Section Chairs: Connie Sun, Ph.D.& Charlene Liao Ph.D.
1:00 PM-1:30 PM Chengdu Kanghong Biotech Co and Conbercept
Jinqun Yin, MBA, Vice President, Chengdu Kanghong Pharmaceutical Group
1:30 PM-2:05 PM Immunotherapy: Past, Present and Future
Mark Selby, Ph.D., Senior Director, Immuno-oncology, Bristol-Myers Squibb
2:05 PM-2:40 PM CRISPR/dCas9 Technology for Genome Manipulation and Disease Research
Stanley Qi Ph.D., Assistant Professor, Department of Bioengineering and Department of Chemical and Systems Biology, Stanford University
2:40 PM-3:15 PM The Art of Partnering
Darren Ji, M.D., Ph.D., MBA, Vice President and Global Head of Roche Partnering, Asia and Emerging Markets
3:15 PM-3:45 PM Key Trends and Case Studies: U.S. – China Cross-Border Life Sciences Investment and Strategic Cooperation
Charles Comey, J.D., Partner, Morrison & Foerster LLP
Afternoon Session II: Trends in BioPharmaceutical Development – China & Global Considerations
Session Chairs: Shichang Miao, Ph.D. & Yang Tian, Ph.D.
4:05 PM-5:20 PM Panel Discussion: BioPharmaceutical Development – China & Global Considerations
(Moderator: Shawn Qian, Ph.D.)
Xian-Ping Lu, Ph.D., Chief Executive Officer & Chief Scientific Officer, Chipscreen Biosciences
Shawn Qian, Ph.D., Co-Founder, Chief Executive Officer & President, NeuPharma
Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen
Dan Zhang, M.D., Ph.D., Chairman & Chief Executive Officer, Fountain Medicine Development Ltd
5:20 PM-5:50 PM Claim Construction Before PTAB and the Courts
Thomas L. Irving, J.D., Partner & Wen Li, Ph.D., Associate, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
5:50 PM-5:55 PM Introduction to Medicilon
Cheni Kwok, Ph.D., CLP, Senior Consultant, Medicilon and Managing Partner, Linear Dreams
5:55 PM-6:00 PM Introduction to Pharmaron
Connie Sun, Ph.D., Senior Vice President, Business and Corporate Development, Pharmaron
6:45 PM-7:30 PM DINNER
Evening Session: US-China Cross-Border Healthcare Investment & Entrepreneurship
Session Chair: Yan Wang, Ph.D.
7:30 PM-9:00 PM Panel Discussion: US-China Cross-Border Healthcare Investment & Entrepreneurship
(Moderator: Alexis Ji Ph.D., MBA)
Min Cui, Ph.D., Founding Partner & Managing Director, Decheng Capital
Alexis Ji, Ph.D., MBA, Principal, WuXi Healthcare Ventures
Shawn Lee, Ph.D., Vice-Chairman, Xinbang Pharmaceuticals; President & CEO, CPC Scientific Inc.
Cheng Liu, Ph.D., Founder & Chief Executive Officer, Eureka Therapeutics
Vincent Liu, Ph.D., Senior Consultant, WanbangBioPharmaceutical, Shanghai Fosun
Pharmaceutical (Group) Co. Ltd.
Yuwen Liu, Founding Partner, Bohe Angel Fund
James Zhao, M.D., Founding Partner, LYFE Capital
Darren Ji, M.D., Ph.D., MBA, Vice President and Global Head of Roche Partnering, Asia and
Emerging Markets
Jennifer Hu, Ph.D., Venture Partner, Qiming Venture Partners